
This 1-week course followed the series of multidisciplinary and innovative training activities organised by the project INBIOMEDvision and was held on the 22-26th of April at the Barcelona Supercomputing Centre (Spain) facilities at the lively University zone located uptown of Barcelona. The course was targeted to post graduate students with interest in the different integrative and translational research approaches in the field of Bioinformatics.
A group of 30 students from 10 different countries were selected to take part in the course based on personal motivation and previous study and research background with a special focus on translational and integrative studies.
The course was jointly organised with the Pompeu Fabra University (UPF), the Bioinformatics Barcelona (BIB), Barcelona Supercomputing Center (BSC), the Spanish Technological Platform for Innovative Medicines (PTEMI), and the Spanish Institute of Bioinformatics (INB). The organising and selection commitee was chaired by Dr. Laura I. Furlong (GRIB, IMIM-UPF), and other members were Prof. Ferran Sanz and Dr. Núria López-Bigas (GRIB, IMIM-UPF).
PharmaTrek, a web-based tool developed by M.Carmen Carrascosa, member of the Chemogenomics group of GRIB (IMIM/ UPF) led by Jordi Mestres, within the framework of the EU funded project Open PHACTS, is officially released. Try it out now: http://www.pharmatrek.org
This tool offers a totally new way of questioning pharmacology databases in a more interactive manner. Please, have a look at the demo video.
Publication Reference: Carrascosa MC, Massaguer OL, Mestres J. PharmaTrek: A Semantic Web Explorer for Open Innovation in Multitarget Drug Discovery. Mol Inf, 2012; 31 (8):537-541. DOI 10.1002/minf.201200070.
The EMIF project aims to develop a common information framework of patient-level data that will link up and facilitate access to diverse medical and research data sources, opening up new avenues of research for scientists. To provide a focus and guidance for the development of the framework, the project will focus initially on questions relating to obesity and Alzheimer’s disease. EMIF is a European project funded by IMI.